Stroke, Vol 18, 52-58, Copyright © 1987 by American Heart Association
RB Duckrow, DC Beard and RW Brennan
The presence of hyperglycemia prior to stroke or cardiac arrest can
increase neuronal damage caused by brain ischemia. Acute hyperglycemia
shows this effect in animal models of stroke. However, chronic
hyperglycemia and chronic hyperglycemia with additional acute elevation of
blood glucose are more common premorbid states for stroke patients. The
effect of chronic hyperglycemia on regional cerebral blood flow (rCBF) is
unclear but blood flow changes may play a role in this ischemic cell
damage. We measured rCBF in awake restrained rats that had chronic
hyperglycemia induced by treatment with streptozotocin. This was compared
to that measured in rats made acutely hyperglycemic by injecting glucose
into the peritoneal space. rCBF was measured in 17 brain regions using
[14C]iodoantipyrine. During chronic hyperglycemia, when plasma glucose was
29 microns/ml, rCBF was decreased and a regional distribution of this
effect was noted; 9 hindbrain regions showed a mean flow decrease of 14%
while forebrain regions demonstrated less flow reduction. Acute elevation
of plasma glucose during normoglycemia or superimposed on chronic
hyperglycemia produced flow reductions of 7% for each 10 microns/ml
increment in plasma glucose up to 60 microns/ml. Both chronic and acute
hyperglycemia are associated with decreased rCBF and the mechanism for this
effect does not appear to adapt to chronic hyperglycemia.
ARTICLES
Regional cerebral blood flow decreases during chronic and acute hyperglycemia
This article has been cited by other articles:
![]() |
C. T. Kodl and E. R. Seaquist Cognitive Dysfunction and Diabetes Mellitus Endocr. Rev., June 1, 2008; 29(4): 494 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Leigh, O. O. Zaidat, M. F. Suri, G. Lynch, S. Sundararajan, J. L. Sunshine, R. Tarr, W. Selman, D. M.D. Landis, and J. I. Suarez Predictors of Hyperacute Clinical Worsening in Ischemic Stroke Patients Receiving Thrombolytic Therapy Stroke, August 1, 2004; 35(8): 1903 - 1907. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Convit, O. T. Wolf, C. Tarshish, and M. J. de Leon Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly PNAS, February 18, 2003; 100(4): 2019 - 2022. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Hasselbalch, G. M. Knudsen, B. Capaldo, A. Postiglione, and O. B. Paulson Blood-Brain Barrier Transport and Brain Metabolism of Glucose during Acute Hyperglycemia in Humans J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1986 - 1990. [Abstract] [Full Text] |
||||
![]() |
G.-J. Biessels, N. A. Cristino, G.-J. Rutten, F. P. T. Hamers, D. W. Erkelens, and W. H. Gispen Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats: Course of development and effects of insulin treatment Brain, April 1, 1999; 122(4): 757 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Lipscomb, L. G. Gorman, R. J. Traystman, P. D. Hurn, and C. Iadecola Low Molecular Weight Iron in Cerebral Ischemic Acidosis In Vivo • Editorial Comment Stroke, February 1, 1998; 29(2): 487 - 493. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1987 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |